Enjoy complimentary customisation on priority with our Enterprise License!
The obsessive-compulsive disorder drugs market size is forecast to increase by USD 348.54 million at a CAGR of 5.93% between 2023 and 2028. The Obsessive-Compulsive Disorder (OCD) drugs market is witnessing significant growth due to the rising prevalence of OCD worldwide. According to the Anxiety and Depression Association of America, OCD affects approximately 1.2% of the population, which equates to over 2.3 million Americans. The market is also driven by the increased use of off-label therapies for OCD treatment, as many patients do not respond to first-line treatments. However, the diagnosis of OCD remains a challenge due to its complex nature and the lack of definitive diagnostic tests. This makes it essential for healthcare providers to rely on a combination of self-reported symptoms, clinical interviews, and observational assessments for diagnosis. Despite these challenges, the market is expected to grow steadily due to the unmet medical needs and the development of novel therapies.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.